Recombinant Proteins Market Size
Recombinant Proteins Market Size was valued at USD 2.34 Billion in 2024 and is expected to reach USD 4.68 Billion by 2034 growing at a CAGR of 7.9%
One of the mainstays of modern biotechnology is recombinant protein technology. They are essential to industrial, medical, and agricultural activities. The word describes proteins that are synthesized artificially. These recombinant proteins are created via genetic engineering methods. In essence, it is the process of isolating the gene that codes for a desired protein, cloning it, and inserting it into the DNA of another host such as yeast or bacteria. The target protein is subsequently produced in large quantities by the host organism using the cellular machinery of the host, functioning as a mini-factory. What makes recombinant proteins valuable is their capacity to express particular proteins in such large quantities.
Among their various use is as a therapeutic: "Recombinant proteins are central to many life-saving medications, for example, insulin against diabetes and growth hormone against dwarfism.” They are used by scientists to create tests for a number of illnesses, including hepatitis and HIV. In other words, researchers use recombinant proteins as essential tools to attempt and understand how proteins operate, how diseases are caused, and how to find new drugs. These proteins can be modified to carry out particular functions in an industrial process, increasing its efficiency and reducing its environmental impact. Numerous fields were transformed by recombinant protein technology. It has prompted the creation of novel medications, diagnostic tools, and potentially cutting-edge research.